Table of Contents
- Quick Summary
- What Are the Treatment Options for Alzheimer’s Disease?
- What Medications Treat Alzheimer’s Disease?
- Lecanemab India: Is There a New Drug for Alzheimer’s?
- What Therapies Help With Dementia Symptoms?
- Physical Activity and Routine as Part of Alzheimer’s Care
- How Can Caregivers Get Support for Dementia Care?
- Can Treatment Help in Advanced Alzheimer’s Disease?
- What Should Families Ask the Doctor About Alzheimer’s Treatment?
- Managing the Financial Burden of Long-Term Alzheimer’s Care
- Conclusion
- Frequently Asked Questions
Quick Summary
- Treatment options for Alzheimer’s disease include medicines for symptoms, supportive therapies, lifestyle measures, and structured care.
- Alzheimer’s medication may help manage memory and thinking symptoms, while some newer drugs target underlying amyloid pathology in early Alzheimer’s disease.
- Occupational therapy, cognitive activities, physical activity, and behavioural approaches can help maintain independence and quality of life.
- Caregiver support for dementia is an important part of treatment because Alzheimer’s gradually affects daily activities and increases care needs.
- Lecanemab is a newer disease-modifying treatment for early Alzheimer’s disease, but its suitability, availability, monitoring requirements, and regulatory status in India need specialist assessment.
Alzheimer’s disease can change much more than a person’s memory. As the condition progresses, familiar routines, communication, decision-making, and everyday activities can become increasingly difficult. For families, this often raises an urgent question: What treatment can actually help?
There is currently no cure that reverses Alzheimer’s disease. However, treatment can help manage symptoms, support daily functioning, address behavioural or psychological difficulties, and in some people with early disease, slow clinical decline. The approach usually combines medication with therapies, safety planning, and caregiver support rather than relying on a single treatment.
This guide explains the main treatment options for Alzheimer’s disease, what different medicines do, how therapies can help, and what families should know about newer treatments such as lecanemab.
What Are the Treatment Options for Alzheimer’s Disease?
Treatment depends on the person’s stage of Alzheimer’s disease, symptoms, overall health, other medicines and care needs. A doctor may recommend a combination of:
- Medicines to manage cognitive symptoms
- Medicines for certain behavioural or psychological symptoms when necessary
- Occupational, cognitive and physical therapies
- Changes to daily routines and the home environment
- Caregiver education and support
- Disease-modifying treatment for eligible people with early Alzheimer’s disease
The goal is not simply to improve a memory-test score. Treatment may also aim to help a person remain independent for as long as possible, participate in meaningful activities, manage symptoms, and maintain quality of life.
For a broader explanation of the condition itself, see our guide to [Alzheimer’s vs Other Dementias: Symptoms and Diagnosis].
What Medications Treat Alzheimer’s Disease?
Alzheimer’s medication generally falls into two broad groups: medicines that help manage symptoms and newer disease-modifying medicines that target some of the underlying changes associated with Alzheimer’s disease.
Cholinesterase Inhibitors for Dementia
Cholinesterase inhibitors increase acetylcholine availability, a chemical involved in memory and other cognitive functions. Commonly used medicines in this group include:
- Donepezil
- Rivastigmine
- Galantamine
They may be prescribed for mild to moderate Alzheimer’s disease, with some medicines also used as the disease progresses. Rivastigmine is available in oral forms and as a transdermal patch.
These medicines do not cure Alzheimer’s disease or restore lost brain function. Their purpose is to help manage symptoms, and their benefits and side effects vary between individuals.
Possible side effects can include nausea, diarrhoea, reduced appetite, dizziness and other gastrointestinal symptoms. The prescribing doctor should determine whether a particular medicine is appropriate, especially when the person takes several medicines or has other medical conditions.
Memantine
Memantine works differently from cholinesterase inhibitors. It affects the brain’s glutamate system and may be used for moderate to severe Alzheimer’s disease. It can also be prescribed alongside donepezil in some cases.
As with other Alzheimer’s medicines, it is not a cure. The doctor may monitor whether symptoms or daily functioning improve enough to justify continuing treatment.
Can Alzheimer’s Medication Slow Disease Progression?
This depends on what type of medicine is being discussed.
Traditional Alzheimer’s medicines such as donepezil, rivastigmine, galantamine, and memantine are primarily used to manage symptoms. They do not stop the underlying disease process.
Newer anti-amyloid medicines are different. They are designed to target amyloid, a protein associated with Alzheimer’s disease, and may slow clinical decline in appropriately selected people with early disease. Lecanemab, for example, targets amyloid-beta and has received traditional FDA approval for adults with early Alzheimer’s disease.
However, these treatments have specific eligibility criteria and risks. They are not appropriate for everyone with Alzheimer’s disease.
Lecanemab India: Is There a New Drug for Alzheimer’s?
Lecanemab is one of the most closely watched newer treatment options for Alzheimer’s disease.
Unlike medicines that mainly manage symptoms, lecanemab is an amyloid-targeting disease-modifying therapy. It is intended for people in the early stages of Alzheimer’s disease, such as those with mild cognitive impairment or mild Alzheimer’s dementia associated with amyloid pathology.
What Is the Status of Lecanemab in India?
India’s regulatory records show activity around lecanemab in 2026. The Central Drugs Standard Control Organisation (CDSCO) listed lecanemab in its July 2026 clinical-trial approvals, and a CDSCO Neurology & Psychiatry committee document from April 2026 records a recommendation for a Phase IV clinical trial evaluating its use in routine clinical practice in India.
However, a clinical-trial or regulatory record should not automatically be interpreted as universal routine availability for patients across India. Whether a person can receive lecanemab depends on the applicable regulatory status, specialist assessment, treatment centre, eligibility and monitoring requirements.
Families considering lecanemab should therefore discuss the option with a neurologist or memory-disorder specialist rather than treating it as a standard replacement for existing Alzheimer’s medication.
Who May Be Considered for Lecanemab?
Lecanemab is intended for a specific group of people with early Alzheimer’s disease rather than people at every stage of dementia. Assessment may involve confirming the diagnosis and the presence of amyloid pathology, along with reviewing the person’s overall health and treatment risks.
The medicine also requires medical monitoring because amyloid-targeting antibodies can cause amyloid-related imaging abnormalities (ARIA), including brain swelling or bleeding.
This is one reason why newer Alzheimer’s treatments should be considered through specialist centres equipped for appropriate evaluation and monitoring.
For information about hospitals and specialist centres, check out our [Best Neurology Hospitals and Memory Care Centers in India.]
What Therapies Help With Dementia Symptoms?
Medication is only one part of Alzheimer’s care. Non-drug therapies can help a person maintain abilities, stay engaged, and manage everyday challenges.
The appropriate therapy depends on the person’s symptoms, abilities, preferences, and stage of disease.
Occupational Therapy for Dementia
Occupational therapy focuses on helping a person participate in everyday activities as safely and independently as possible.
An occupational therapist may work on:
- Dressing and grooming
- Eating and meal routines
- Household activities
- Using familiar objects
- Managing daily schedules
- Adapting the home for safety
- Maintaining meaningful hobbies and activities
Evidence-based occupational therapy guidelines for Alzheimer’s disease and related neurocognitive disorders support interventions including reminiscence, exercise, non-pharmacological behavioural approaches, cognitive therapy, sensory interventions and education for care partners.
The objective is not to force a person to perform tasks they can no longer manage. Instead, activities can be adapted to their current abilities so they can participate without unnecessary frustration.
Cognitive and Meaningful Activities
Simple, familiar activities can help keep a person’s day structured and meaningful. Depending on their abilities, these may include:
- Looking through family photographs
- Listening to familiar music
- Gardening
- Folding clothes
- Simple games
- Reading or storytelling
- Short walks
- Helping with familiar household tasks
The National Institute on Aging recommends adapting activities to the person’s abilities, helping them get started when needed, and watching for signs of frustration.
This approach matters because dementia care is not only about treating symptoms. It is also about preserving a person’s sense of familiarity, participation, and dignity.
Physical Activity and Routine as Part of Alzheimer’s Care
Regular physical activity may be included in a person’s care plan when medically appropriate. Walking, balance exercises, stretching, and other suitable activities can support general health and help maintain mobility.
A predictable daily routine can also make everyday life easier. Keeping meals, medication, bathing, exercise, and bedtime around consistent times may reduce confusion for some people.
The routine should remain flexible. If an activity consistently causes distress or exhaustion, caregivers can shorten it, simplify it, or try it at another time of day.
For practical guidance on day-to-day care, check out [Caring for a Loved One with Dementia: A Practical Guide] here.
How Can Caregivers Get Support for Dementia Care?
Caring for someone with Alzheimer’s can gradually become a full-time responsibility. As the disease progresses, a person may need help with medication, meals, bathing, dressing, mobility, appointments, finances, and safety.
That does not mean one family member has to manage everything alone.
Caregiver support for dementia can include:
- Family members sharing responsibilities
- Home-care or nursing assistance
- Occupational or physical therapy
- Support groups
- Respite care
- Adult day-care services
- Professional counselling where appropriate
- Long-term or memory-care facilities when home care is no longer practical
The National Institute on Aging notes that Alzheimer’s caregiving can exceed what one person can reasonably provide and encourages caregivers to seek help when they need it. Support may come from family and friends, community organisations, support groups and professional care services.
India’s National Programme for Health Care of the Elderly also includes geriatric medical care, rehabilitation and home-based care within its broader framework for older adults.
When Should Families Consider Professional or Long-Term Care?
There is no single point at which every family should move a person with dementia into residential care.
The decision may depend on:
- The person’s safety at home
- Wandering or fall risk
- Ability to eat and take medicines safely
- Need for round-the-clock supervision
- Behavioural or psychological symptoms
- Availability of family caregivers
- The physical and financial capacity of the household
Families exploring residential options can also read [Old Age Homes in India] or the relevant city-specific old-age-home guides.
For the financial side of long-term care, check out [Cost of Alzheimer’s and Dementia Care in India].
Can Treatment Help in Advanced Alzheimer’s Disease?
Treatment remains important even when Alzheimer’s disease has progressed.
The focus may shift from preserving independence to:
- Managing discomfort and medical complications
- Preventing falls and injuries
- Supporting nutrition and hydration
- Managing behavioural symptoms
- Maintaining communication
- Providing personal care
- Supporting family caregivers
- Preserving dignity and comfort
Some medicines may no longer provide enough benefit to justify their side effects or monitoring requirements. Doctors may therefore reassess the treatment plan as the disease progresses.
This is also why Alzheimer’s treatment should be reviewed periodically rather than continuing every medicine indefinitely without reassessment.
What Should Families Ask the Doctor About Alzheimer’s Treatment?
Before starting or changing treatment, families can ask:
- What stage of Alzheimer’s disease is this?
- What is the goal of this medicine or therapy?
- How long might it take to notice a benefit?
- What side effects should we watch for?
- Does this medicine interact with the person’s existing medicines?
- Would occupational therapy or another therapy help with current difficulties?
- Does the person need assessment for a newer disease-modifying treatment?
- What monitoring or scans would be required?
- When should treatment be reviewed?
- What support is available for the caregiver?
These questions can make appointments more useful and help families understand why each part of the treatment plan has been recommended.
Managing the Financial Burden of Long-Term Alzheimer’s Care
Alzheimer’s disease treatment options can involve expenses that continue for years rather than ending after a single hospital visit. Families may have to plan for medicines, specialist consultations, diagnostic tests, therapy, nursing, home modifications, and long-term care.
If treatment or caregiving expenses become difficult to manage, families may explore insurance, government schemes, charitable assistance, and crowdfunding in India.
A medical crowdfunding campaign can allow relatives and friends to contribute towards eligible treatment and care-related expenses. Families considering this route can learn more through our guide on [Crowdfunding for Long-Term Alzheimer’s and Dementia Care].
ImpactGuru provides a platform through which individuals and families can raise funds for medical needs, subject to its applicable verification and fundraising processes.
Conclusion
Alzheimer’s disease treatment options can combine medication, therapy, meaningful daily activities, safety measures, and support for the person providing care. Earlier stages may offer more treatment options, while later care often places greater emphasis on comfort, safety, and quality of life.
If the cost of ongoing treatment, nursing or dementia care becomes difficult for your family to manage, financial assistance may be available through insurance, government or charitable resources. Medical crowdfunding can also help families seek support from their wider community. ImpactGuru can help eligible families raise donations online for medical needs through a structured fundraising process.
Before starting, stopping, or changing Alzheimer’s treatment, always discuss the options with the treating neurologist or other qualified healthcare professional.
Frequently Asked Questions
Common medicines used to manage Alzheimer’s symptoms include donepezil, rivastigmine, galantamine, and memantine. The choice depends on the person’s symptoms, disease stage, health conditions,s and other medicines.
Traditional Alzheimer’s medicines mainly manage symptoms rather than stopping the underlying disease. Newer disease-modifying treatments such as lecanemab are designed to target amyloid pathology and can slow clinical decline in appropriately selected people with early Alzheimer’s disease.
Occupational therapy, cognitive activities, exercise, behavioural approaches, sensory activities, and caregiver education may help address functional, cognitive, and behavioural challenges. The right combination depends on the person’s abilities and needs.
Designation: Content Writer
Expertise: Healthcare, Crowdfunding, Research
Navpreet Kaur is a Healthcare Research Analyst at ImpactGuru, creating educational and informational content focused on healthcare awareness, medical fundraising, and patient support in India.







